Reuters logo
BRIEF-Pfizer says Hospira deal would not delay possible breakup of Pfizer by 2017
February 5, 2015 / 2:47 PM / in 3 years

BRIEF-Pfizer says Hospira deal would not delay possible breakup of Pfizer by 2017

Feb 5 (Reuters) - Pfizer Inc : * Says Hospira deal would not delay timing of possible breakup of

Pfizer by 2017 * CEO says likes the hospital pump business and aims to remain in it * CFO says it would have to pay a $500 million breakup fee if it were to

abandon Hospira deal * CFO says company buying Hospira “at a fair price,” will be partially financed

by overseas Pfizer cash * CFO says deal would not change pfizer’s expected 2015 tax rate of about 25

percent * CEO says does not expect hospira’s biosimilars partnership with celltrion ”to

be a major issue” in deal

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below